
GC62425
ARN-21934
Also known as 4-N-[4-(dimethylamino)phenyl]-2-pyridin-4-yl-5,6,7,8-tetrahydroquinazoline-4,6-diamine
ARN-21934 is a potent, highly selective, blood-brain barrier (BBB) penetrant inhibitor for human topoisomerase II α over β· ARN-21934 inhibits DNA relaxation with an IC50 of 2 μM as compared to the anticancer agent Etoposide (IC50=120 μM)· ARN-21934 exhibits a favorable in vivo pharmacokinetic profile and is a promising lead compound for anticancer research
ChemicalCAS2230854-93-8MW360.46FormulaC21H24N6
- CAS number
- 2230854-93-8
- Molecular weight
- 360.46
- Formula
- C21H24N6
- Solubility
- DMSO : 8·33 mg/mL (23·11 mM; ultrasonic and warming and heat to 80°C)
- InChIKey
- CKXSRLUXTFDZCF-UHFFFAOYSA-N
- Catalogue number
- GC62425
- Brand
- GLPBIO
Computed properties PubChem CID 135150944 · XLogP 2.6 · TPSA 80 Ų · H-bond donors 2
- XLogP
- 2.6
- TPSA
- 80 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 27
SMILES CN(C)C1=CC=C(C=C1)NC2=NC(=NC3=C2CC(CC3)N)C4=CC=NC=C4
Computed descriptors from PubChem (CID 135150944), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il